Gastric ulceration is one of the most common diseases found in horses \[[@r12], [@r32], [@r34]\]. Some horses exhibit clinical signs, but others develop silent gastric ulceration (also known as subclinical or non-clinical gastric ulceration), and both types can affect a horse's performance and health \[[@r1], [@r16], [@r35]\].

The most accurate method of diagnosing equine gastric ulceration is gastroscopy \[[@r32]\], but this technique is unsuitable as a screening test due to the need for expensive equipment, the complicated procedure, and the fact that it is time-consuming to perform \[[@r15]\]. A faecal blood test and sucrose permeability test can be used for screening the disease, but their sensitivity and specificity are much lower than gastroscopy \[[@r11], [@r39]\].

Detection of disease-specific proteins (biomarkers) in blood is rapid, practical, and effective, and many commercial biomarker kits have been developed for detecting human diseases \[[@r21]\]. Proteomic technologies including electrophoresis and mass spectrometry have been used to identify protein biomarkers for gastric diseases such as *H. pylori* infection associated with gastric ulceration and cancer in humans \[[@r29]\] and gastric ulceration in foals \[[@r33]\]. A study in foals revealed alpha (1)-antitrypsin as a candidate marker for gastric ulceration \[[@r33]\], but this protein has not been developed for clinical use. Other equine diseases such as laminitis and osteoarthritis have also been investigated to identify disease markers by using proteomic technologies \[[@r5], [@r31]\].

However, albumin is the most abundant protein in serum \[[@r24]\], and it can conceal the candidate biomarker proteins, which are usually low-abundance proteins \[[@r18]\]. Therefore, it is essential to eliminate albumin before proteomic analysis \[[@r9]\]. In human analyses, serum/plasma albumin is usually depleted by using column immunoaffinity purification or commercial albumin removal kits \[[@r30]\]. Unfortunately, there is no commercial kit available specifically for horses, and most kits for human samples inefficiently remove equine albumin \[[@r22]\]. Additionally, there is also a lack of published reports relating to the protocol of serum albumin removal in horses.

Trichloroacetic acid (TCA) protein precipitation is a common method used for proteins precipitation \[[@r20]\]. It is an analogue of acetic acid, and at the optimal concentration in suitable organic solvents, it selectively binds to albumin \[[@r26]\]. The TCA protein precipitation method has been used to remove or purify albumin from serum from several species \[[@r3], [@r9], [@r14], [@r23]\]. The objectives of this study were to optimise the protocol to remove horse serum albumin and to use albumin-depleted serum to identify protein biomarkers for silent gastric ulceration.

Materials and Methods {#s1}
=====================

A summary of the experimental design is shown in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Diagram of the experimental study..

Animals
-------

Equine serum was obtained from a previous study, in which we investigated the occurrence of gastric ulceration in Thoroughbred horses by using gastroscopy \[[@r35]\]. Horse ages were between 7--15 years old, and body weights were 400--450 kg. Recorded videos and images of gastric ulcerations were obtained from the previous study \[[@r35]\] and graded as recommended by the Equine Gastric Ulcer Council \[[@r32]\]. Horses were sedated with 0.5--1 mg/kg xylazine hydrochloride intravenously before performing video gastroscopy (Model GVE 2100A2, Huger Medical Instrument, Shanghai, China). Ten millilitres of blood were collected from the jugular vein, and samples from 10 horses with a normal gastric mucosa and 10 horses with silent gastric ulceration (at non-glandular stomach) were collected.

This research project was approved by the Animal Care and Use Committee of the Faculty of Veterinary Science, Mahidol University. The horse owner (Veterinary and Remount Department of the Royal Thai Army) provided informed consent for gastroscopy, blood collection, and the proteomic study.

Optimisation of TCA-protein precipitation protocols for removal of albumin
--------------------------------------------------------------------------

The protocol optimisation included varying the concentration (1, 5, 10, or 20%) of TCA (AppliChem GmbH, Darmstadt, Germany) in several different organic solvents including ethanol, methanol, isopropanol, and acetone (V.S. Chem House, Bangkok, Thailand). Two dilution ratios (1:5 and 1:10) of serum to protein precipitation solution (TCA in an organic solvent) and two incubation times (45 and 90 min) were also compared.

Pooled serum (20 *µl*) was mixed with either 80 *µl*(1:5) or 180 *µl*(1:10) of ice-cold TCA-organic solvents and incubated at −20°C for either 45 or 90 min for precipitation. After centrifugation at 15,000 × g for 10 min, the pellets (albumin-depleted fraction) and supernatant (albumin-enriched fraction) were separately collected. Both pellets and supernatants were added with 1 m*l* of cold solvents and then centrifuged at 15,000 g for 10 min. At this step, albumin-enriched proteins in the supernatant were precipitated, and the supernatants were removed. Then both pellets were evaporated and resuspended with 50 *µl* of buffer containing 8 M urea (Research Organics, Cleveland, OH, U.S.A.), 4% W/V CHAPS (AppliChem GmbH), 15 mM DTT (Vivantis Technologies, Selangor Darul Ehsan, Malaysia), 0.15% IPG buffer (GE Healthcare, Uppsala, Sweden), and 0.001% bromophenol blue (VWR International, Radnor, PA, U.S.A.). Protein concentration was quantified using a Pierce™ BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA, U.S.A.).

Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
---------------------------------------------------------------------

Two micrograms of sample from the crude serum, the albumin-enriched fraction, or albumin-depleted fraction were mixed with 15 *µl* of loading buffer containing 0.2 M Tris (Bio Basic, Markham, ON, Canada; pH 6.8), 20% glycerol (Bio Basic), 10% SDS (Bio-Rad, Hercules, CA, U.S.A.), and 5% β-mercaptoethanol (EuroClone, Pero, MI, Italy) and then boiled at 95°C for 10 min. The mixtures were loaded on 8% SDS gels in a Mini-PROTEAN system (Bio-Rad) at 90 V for 90 min or until the dye front reached the bottom at the end of the gels. The gels were washed with distilled water and subsequently stained with 1% Coomassie brilliant blue R250 (Thermo Fisher Scientific) for 2 hr. Excess dye was washed with destaining solution (10% methanol and 7% glacial acetic acid) for at least 2 hr.

Image analysis
--------------

The protein bands were imaged using a scanner (DocuPrint CM215b, Fuji Xerox, Bangkok, Thailand). The percentage of albumin and IgG removal was calculated by measuring the density of protein bands and comparing between pre- and post-protein precipitation. The density of protein bands was measured by using the ImageJ software \[[@r28]\].

In-gel protein digestion and mass spectrometry analysis
-------------------------------------------------------

The specific protein bands were excised, and digestion with trypsin was performed according to previous reports \[[@r10]\]. The analysis of extract peptides was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Briefly, the extracted peptides were injected into the LC-MS/MS device with the ESI-QUAD-TOF technique. An UltiMate 3000 Nano and Capillary LC system (Dionex, Sunnyvale, CA, U.S.A.) and a maXis mass spectrometer detector (Bruker, Billerica, MA, U.S.A.) were used. Protein identification was performed using the Mascot 2.3 software (Matrix Science, Boston, MA, U.S.A.) connected to the *Equus caballus* NCBI database.

Statistics
----------

Percentages of protein removal are shown as the mean ± standard error of the mean (SEM). Statistical differences were calculated using the IBM SPSS 21 software (IBM, Armonk, NY, U.S.A.). One-way ANOVA and multiple comparisons with LSD testing were used for comparison of more than 2 subjects. Student's *t*-test was used for comparison between two samples.

Results {#s2}
=======

The optimal protocols for equine albumin removal
------------------------------------------------

After screening 64 protocols, the best five protocols were identified. These were found to be protocols 1, 2, 3, 21, and 22 ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Screening of 64 protocols for removing serum albumin. Optimisation was performed by varying the organic solvents, percentage of TCA, serum per protein precipitation solutions, and incubation times. The five best protocols are marked with black circles. Acetone was used in protocols 1--16, isopropanol was used in protocols 17--32, ethanol was used in protocols 33--48, and methanol was used in protocols 48--64.). These five conditions efficiently removed albumin (\>90%) and did not degrade proteins. Protocols 1--3 used acetone, while protocols 21 and 22 used isopropanol as an organic solvent. Ethanol and methanol were unable to efficiently remove albumin compared with acetone and isopropanol ([Fig. 2](#fig_002){ref-type="fig"}).

We then repeated these five protocols in triplicate and calculated the efficiency of albumin and IgG depletion ([Table 1](#tbl_001){ref-type="table"}Table 1.The five optimal conditions of the albumin removal protocolProtocolSerum:solutionTCA (%)SolventsIncubation (min)Depletion (%)AlbuminIgG (heavy)IgG (light)11:520Acetone9096.94 ± 0.0267.66 ± 0.8788.92 ± 2.5221:510Acetone9097.85 ± 0.0779.54 ± 0.29\*98.12 ± 0.18\*31:55Acetone9092.13 ± 0.1321.20 ± 5.4755.60 ± 1.67211:1020Isopropanol9094.41 ± 0.0980.15 ± 0.06\*75.37 ± 2.37221:1010Isopropanol9095.03 ± 0.1779.19 ± 0.97\*72.46 ± 3.23The percentage of albumin and IgG removal is presented as the mean ± SEM. \*Represents significant difference (*P*\<0.05).). In this study, the molecular weights of albumin, IgG heavy chain, and IgG light chain were approximately 65, 45, and 25 kDa, respectively. All five optimised protocols removed albumin efficiently with depletion rates of more than 90%. However, the ability to remove IgG heavy and light chains differed among the protocols. Protocols 2, 21, and 22 were comparable with respect to removing IgG heavy chain (about 80% removal efficiency) and were significantly better (*P*\<0.05) than protocols 1 and 3. For IgG light chain, protocol 2 was significantly superior to the other protocols (*P*\<0.05), as it was able to remove up to 98% of IgG light chain protein. Taking these together, protocol 2 was superior to the other protocols due to its ability to remove both albumin and IgG efficiently.

The physical appearance of silent gastric ulcer horses compared to normal horses
--------------------------------------------------------------------------------

From the records of our previous study \[[@r35]\], the physical appearances of healthy and silent gastric ulcer horses were similar, and both appeared normal. The gastric epithelium of normal horses had no lesions of ulceration or hyperkeratosis, and the gastric epithelium was intact (Grade 0). All horses with silent gastric ulceration had multiple small ulcers but less than five lesions which presented at the superficial layer of the non-glandular mucosa near the margo plicatus (Grade I--II).

The differential protein expression in horse serum between normal gastric mucosa and silent gastric ulceration groups
---------------------------------------------------------------------------------------------------------------------

Protocol 2 was used to remove albumin, and then gel electrophoresis was performed to compare the protein patterns between normal gastric mucosa and silent gastric ulceration groups. There was clearly a difference in density of protein bands at a molecular weight of approximately 75 kDa ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Gel electrophoresis. The white rectangle represents 75 kDa proteins with densities that differ between normal and silent gastric ulceration horses. The protein bands for albumin, IgG heavy chain (IgG-H), and IgG light chain (IgG-L) are indicated with black arrows. UCS, undiluted crude serum; DCS, diluted crude serum (1:40 dilution); ADF, albumin-depleted protein fractions; AEF, albumin-enriched fractions (1:40 dilution); M, protein marker; N, pooled serum from normal gastric mucosa horses; U, pooled serum from silent gastric ulceration horses.) when comparing normal and silent gastric ulceration horses. These protein bands from protocol 2 were excised for mass spectrometry analysis, which identified four proteins from silent gastric ulceration horses. These proteins were keratin type II cytoskeletal 1 (KRT1), keratin type II cytoskeletal 6A isoform X1 (KRT6A), keratin type I cytoskeletal 18 (KRT18), and transferrin (TF) ([Table 2](#tbl_002){ref-type="table"}Table 2.Proteins identified by mass spectrometry in serum from silent gastric ulceration horseAccession No.Protein nameProtein scoreProtein mass (Da)Peptide sequencesgi338726100Keratin 16764,976TLLEGEESRgi149714759Keratin type II cytoskeletal 6A isoform X13961,223AQYEEIAQRgi545220094Keratin type I cytoskeletal 183948,343AQYEELARKgi136190Transferrin3780,268KNSNFQLNQLQGKgi335773196Septin-7-like protein1950,673SPLAQMEEERREHVAKMK). The proteins from normal horses were identified as TF, splicing factor, arginine/serine-rich 19 (SCAF1), and prolow-density lipoprotein receptor-related protein 1 (LRP1) ([Table 3](#tbl_003){ref-type="table"}Table 3.Proteins identified by mass spectrometry in horse with a normal mucosaAccession No.Protein nameProtein scoreProtein mass (Da)Peptide sequencesgi136190Transferrin21780,268DSALGFLRgi953864613Splicing factor, arginine/serine-rich 1925103,446MEEEDESRGKTEESGEDRgi545220722Prolow-density lipoprotein receptor-related protein 119516,445GGRILQEDFTCRAVNSSCR).

Discussion {#s3}
==========

The present study showed that the most efficient protocol to remove equine albumin and IgG from serum samples used 10% TCA in acetone as the protein precipitation solution. The optimal ratio of serum to protein precipitation solution was 1:10, and the optimal incubation time for precipitation was 90 min. This is consistent with the results of Chen *et al.* \[[@r3]\], who reported that 5--10% TCA in acetone is the optimal condition for removing human albumin and IgG, but Liu *et al.* \[[@r14]\] reported that 1% TCA in isopropanol is the optimal solution to remove albumin from human and monkey serum for a proteomic study. Notably, our protocol is simple and inexpensive, and it is more efficient than using human commercial kits to remove equine serum albumin and IgG \[[@r22]\].

The epithelium of the non-glandular part of the equine stomach is a stratified squamous epithelium, which is similar to the epithelial type found in the oesophagus and skin \[[@r2], [@r8]\]. Most squamous epithelia express a variety of keratins which provide structural integrity between the cells \[[@r37]\]. The present study found 3 types of keratins (KRT1, KRT6A, and KRT18) in serum of horses which had silent gastric ulceration. KRT18 is the most commonly found member of these keratins and is found in many tissues, while KRT1 and KRT6A are specifically expressed in the normal stratified squamous epithelium of the oesophagus \[[@r37]\]. KRT1 is associated with chronic disease such as inflammatory bowel disease in humans \[[@r7]\]. KRT6A expression is important and high during wound healing in the stratified squamous epithelium \[[@r6], [@r40]\] and associated with mucosal change, ulceration, and hyperkeratosis in the oesophagus and pars oesophagea of pigs \[[@r13], [@r25]\], where it has a similar structure to the non-glandular part of the equine stomach \[[@r2], [@r8]\].

TF is an iron transportation protein, and it may be associated with gastric ulceration when gastric haemorrhage occurs, resulting in a reduction of serum TF \[[@r4], [@r42]\]. The leaked TF in the gastrointestinal tract can be detected and used to diagnose peptic ulcer with haemorrhage \[[@r4]\].

The other three proteins identified are not specifically expressed in the GI tract and/or are unrelated with gastric ulceration in the non-glandular stomach. Septin-7-like protein may have similar function to septin 7 protein which is expressed in many tissues \[[@r37]\] and involved in cytoskeleton organization, cytokinesis, and membrane dynamics \[[@r19]\]. SCAF1 can be found in almost all tissues in the body \[[@r37]\] and is involved in pre-mRNA splicing \[[@r36]\]. LRP1 is a receptor found in many tissues, and it is involved in several cellular processes, including intracellular signalling, and apoptosis \[[@r36], [@r37]\]. LRP1 modulates the inflammatory response, autophagy, and apoptosis in human gastric ulcers caused by *Helicobacter pylori* infection \[[@r17], [@r41]\].

In the present study, horses with silent gastric ulceration had no clinical signs, but they had multiple small ulcers at the superficial layer of the non-glandular stomach close to the margo plicatus. This area is commonly affected by gastric ulcers due to its exposure to acid and pepsin from the glandular stomach \[[@r27], [@r38]\]. From our observations, silent gastric ulceration can be found in approximately 33% of non-working Thoroughbred horses and in about 77% of horses with gastric ulceration \[[@r35]\]. This is consistent with the results of Vatistas *et al.* \[[@r38]\], who found that 80% of Thoroughbred racehorses with gastric ulcer have no relevant clinical signs.

It may be concluded from our study that the best conditions for equine serum albumin and IgG removal by the TCA protein precipitation method are use of 10% TCA in acetone as the precipitation solution and precipitation by dilution of serum in the precipitation solution at a ratio 1:5 and incubation at −20°C for 90 min. The candidate protein biomarkers for equine silent gastric ulceration in the non-glandular stomach are KRT1, KRT6A, and KRT18. Notably, KRT6A may be the most relevant biomarker, as it is expressed in a tissue-specific manner in the non-glandular stomach and its expression is high during gastric ulcer development. Although proteomics is a powerful tool to screen protein biomarkers, confirmation of candidate markers with specific antibodies in a larger study cohort is required before they can be applied at veterinary clinics or horse farms.
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